Inven Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 3.20 M
- Company Age 40 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.02 Cr
- Satisfied Charges ₹ 1.60 Cr
- Revenue Growth 13.36%
- Profit Growth 181.47%
- Ebitda -7.06%
- Net Worth 1.21%
- Total Assets -2.81%
About Inven Pharmaceuticals
Inven Pharmaceuticals Private Limited (IPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 December 1984 and has a history of 40 years and two months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.20 M.
The company currently has active open charges totaling ₹9.02 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sohil Patni, Urvashi Patni, and Manju Patni serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MP1984PTC002701
- Company No.
002701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Pharma
Who are the key members and board of directors at Inven Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sohil Patni  | Managing Director | 05-Nov-2014 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Urvashi Patni | Whole-Time Director | 01-Dec-2015 | Current |
| Manju Patni | Whole-Time Director | 17-Jun-2006 | Current |
Financial Performance of Inven Pharmaceuticals.
Inven Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.36% increase. The company also saw a substantial improvement in profitability, with a 181.47% increase in profit. The company's net worth moved up by a moderate rise of 1.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inven Pharmaceuticals?
In 2023, Inven Pharmaceuticals had a promoter holding of 99.22% and a public holding of 0.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹90.19 M
Satisfied Charges
₹16.04 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 9.00 Cr
- State Bank Of Indore : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2009 | Hdfc Bank Limited | ₹9.00 Cr | Open |
| 29 Oct 1990 | State Bank Of Indore | ₹0.19 M | Open |
| 17 Jan 1995 | State Bank Of Indore | ₹1.00 M | Satisfied |
| 17 Jan 1995 | State Bank Of Indore | ₹1.50 M | Satisfied |
| 29 Mar 1994 | Madhya Pradesh Finance Corporation | ₹1.10 M | Satisfied |
How Many Employees Work at Inven Pharmaceuticals?
Inven Pharmaceuticals has a workforce of 85 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inven Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
